Add to ORKGEfficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysi
Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately em...
Background: Chemotherapy induced nausea and vomiting (CINV) remains one of the most common and debil...
PURPOSE: The control of nausea and vomiting induced by chemotherapy is paramount for overall treatme...
Abstract: Palonosetron, the second generation 5-hydroxytryptamine-3 receptor antagonist (5-HT3RA), h...
Introduction: The second-generation 5-hydroxytryptamine-3 (5-HT3) receptor antagonist palonosetron i...
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and gr...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
Aims and background. In 2003, the second-generation, 5-HT3 receptor antagonist (5-HT3 RA) palonosetr...
Significant progress has been made in the development of effective, convenient and well-tolerated me...
Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women recei...
Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the pr...
<p><b>Introduction</b>: Chemotherapy-induced nausea and vomiting are adverse effects responsible for...
mouth and ype 3 (5-HT3) d role in the their efficacy tiemetics [6]. as focused on f these com-Lee et...
Objective: This review provides an update review of the efficacy and safety of 5-hydroxytryptamine-3...
Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately em...
Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately em...
Background: Chemotherapy induced nausea and vomiting (CINV) remains one of the most common and debil...
PURPOSE: The control of nausea and vomiting induced by chemotherapy is paramount for overall treatme...
Abstract: Palonosetron, the second generation 5-hydroxytryptamine-3 receptor antagonist (5-HT3RA), h...
Introduction: The second-generation 5-hydroxytryptamine-3 (5-HT3) receptor antagonist palonosetron i...
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and gr...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
Aims and background. In 2003, the second-generation, 5-HT3 receptor antagonist (5-HT3 RA) palonosetr...
Significant progress has been made in the development of effective, convenient and well-tolerated me...
Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women recei...
Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the pr...
<p><b>Introduction</b>: Chemotherapy-induced nausea and vomiting are adverse effects responsible for...
mouth and ype 3 (5-HT3) d role in the their efficacy tiemetics [6]. as focused on f these com-Lee et...
Objective: This review provides an update review of the efficacy and safety of 5-hydroxytryptamine-3...
Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately em...
Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately em...
Background: Chemotherapy induced nausea and vomiting (CINV) remains one of the most common and debil...
PURPOSE: The control of nausea and vomiting induced by chemotherapy is paramount for overall treatme...